For the Greatest Impact, End Caps on PrEP Access Now

The Lancet HIV - United Kingdom
doi 10.1016/s2352-3018(19)30006-2
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy